Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies.

MLA

Kandeil, Ahmed, et al. “Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies.” Vaccines, vol. 9, no. 3, Mar. 2021. EBSCOhost, https://doi.org/10.3390/vaccines9030214.

APA

Kandeil, A., Mostafa, A., Hegazy, R. R., El-Shesheny, R., El Taweel, A., Gomaa, M. R., Shehata, M., Elbaset, M. A., Kayed, A. E., Mahmoud, S. H., Moatasim, Y., Kutkat, O., Yassen, N. N., Shabana, M. E., GabAllah, M., Kamel, M. N., Abo Shama, N. M., El Sayes, M., Ahmed, A. N., … Ali, M. A. (2021). Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies. Vaccines, 9(3). https://doi.org/10.3390/vaccines9030214

Chicago

Kandeil, Ahmed, Ahmed Mostafa, Rehab R Hegazy, Rabeh El-Shesheny, Ahmed El Taweel, Mokhtar R Gomaa, Mahmoud Shehata, et al. 2021. “Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies.” Vaccines 9 (3). doi:10.3390/vaccines9030214.